Halper Sadeh LLC Encourages CytoDyn Inc. Shareholders to Contact the Firm to Discuss Their Rights

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of CytoDyn Inc. [1] Group 1 - The investigation pertains to whether the actions of CytoDyn's leadership have harmed shareholder interests [1] - Shareholders who acquired CytoDyn stock on or before March 27, 2020, may have options for seeking corporate governance reforms [1] - Potential remedies for shareholders include the return of funds to the company, court-approved financial incentive awards, or other forms of relief and benefits [1]